PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 µM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 µM, respectively), PAT-1251 is used in the research of fibrotic diseases[1].
Molekulargewicht:
399.34
Reinheit:
99.52
CAS Nummer:
[2007885-39-2]
Formel:
C18H17F4N3O3
Target-Kategorie:
Monoamine Oxidase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
